Lung Cancer:

Prevention, Management, and Emerging Therapies

Nonfiction, Health & Well Being, Medical, Specialties, Pulmonary & Thoracic, Oncology
Cover of the book Lung Cancer: by , Humana Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781607615248
Publisher: Humana Press Publication: March 10, 2010
Imprint: Humana Language: English
Author:
ISBN: 9781607615248
Publisher: Humana Press
Publication: March 10, 2010
Imprint: Humana
Language: English

Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. It kills almost as many Americans as cancers of the breast, prostate, colon, rectum, pancreas, and 2 kidney combined, and accounts for 28.6% of all US cancer deaths. With an increase in the 5-year relative survival rate from 13% to only 16% in the more than 2 30 years from 1974 to the present, it will take us another 840 years to eradicate lung cancer deaths if we do not improve the current rate of progress. As discussed in this text, lung cancer prevention has received substantial att- tion. The decrease in smoking in recent decades has helped, but smoking is not the only problem. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States. Several factors contribute to the lethality of lung cancer, including the rapidity of tumor growth, advanced stage at diagnosis (due to nonspecificity of early sy- toms and the uncertain efficacy of screening), early development of metastases, and resistance to therapy. Several chapters in this book discuss new molecular targets that may be potentially exploitable in the future, as well as discussing our track record to date in exploiting them.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. It kills almost as many Americans as cancers of the breast, prostate, colon, rectum, pancreas, and 2 kidney combined, and accounts for 28.6% of all US cancer deaths. With an increase in the 5-year relative survival rate from 13% to only 16% in the more than 2 30 years from 1974 to the present, it will take us another 840 years to eradicate lung cancer deaths if we do not improve the current rate of progress. As discussed in this text, lung cancer prevention has received substantial att- tion. The decrease in smoking in recent decades has helped, but smoking is not the only problem. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States. Several factors contribute to the lethality of lung cancer, including the rapidity of tumor growth, advanced stage at diagnosis (due to nonspecificity of early sy- toms and the uncertain efficacy of screening), early development of metastases, and resistance to therapy. Several chapters in this book discuss new molecular targets that may be potentially exploitable in the future, as well as discussing our track record to date in exploiting them.

More books from Humana Press

Cover of the book Stem Cells and Cancer by
Cover of the book Adult Stem Cells by
Cover of the book Acute Gastrointestinal Bleeding by
Cover of the book On the Bridge by
Cover of the book Biennial Review of Infertility by
Cover of the book Supportive Care in Cancer Therapy by
Cover of the book Biological Treatment Processes by
Cover of the book Epithelial Transport Physiology by
Cover of the book Asymptomatic Atherosclerosis by
Cover of the book Neurobiology of Spinal Cord Injury by
Cover of the book Magnesium in Human Health and Disease by
Cover of the book Studies on Alzheimer's Disease by
Cover of the book Chronic Leukemias and Lymphomas by
Cover of the book Surgical Treatment of Parkinson’s Disease and Other Movement Disorders by
Cover of the book Beyond Anthrax by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy